Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

IA Khasabova, SG Khasabov, JK Olson, ML Uhelski… - Pain, 2019 - journals.lww.com
Painful peripheral neuropathy is a dose-limiting side effect of cisplatin treatment. Using a
murine model of cisplatin-induced hyperalgesia, we determined whether a PPARg synthetic …
被引用次数：58 相关文章

Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

IA Khasabova, SG Khasabov, JK Olson… - Pain, 2019 - mdanderson.elsevierpure.com
Painful peripheral neuropathy is a dose-limiting side effect of cisplatin treatment. Using a
murine model of cisplatin-induced hyperalgesia, we determined whether a PPARγ synthetic …

Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

IA Khasabova, SG Khasabov, JK Olson, ML Uhelski… - Pain, 2019 - hero.epa.gov
Painful peripheral neuropathy is a dose-limiting side effect of cisplatin treatment. Using a
murine model of cisplatin-induced hyperalgesia, we determined whether a PPARγ synthetic …

Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

IA Khasabova, SG Khasabov, JK Olson… - Pain, 2019 - pubmed.ncbi.nlm.nih.gov
Painful peripheral neuropathy is a dose-limiting side effect of cisplatin treatment. Using a
murine model of cisplatin-induced hyperalgesia, we determined whether a PPARγ synthetic …
[PDF] researchgate.net

[PDF][PDF] Pioglitazone, a PPARg agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

IA Khasabovaa, SG Khasabova, JK Olsona… - PAIN, 2019 - researchgate.net
Painful peripheral neuropathy is a dose-limiting side effect of cisplatin treatment. Using a
murine model of cisplatin-induced hyperalgesia, we determined whether a PPARg synthetic …

[引用][C] Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

IA Khasabova, SG Khasabov, JK Olson, ML Uhelski… - Pain, 2019 - elibrary.ru
The authors thank Catherine Harding-Rose and Matthew Tracy for technical assistance, and
they are especially grateful to Dr Tamila Bulat for valued discussions related to clinical …

Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

IA Khasabova, SG Khasabov, JK Olson, ML Uhelski… - Pain, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Painful peripheral neuropathy is a dose-
limiting side effect of cisplatin treatment. Using a murine model of cisplatin-induced …

Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

IA Khasabova, SG Khasabov, JK Olson, ML Uhelski… - Pain, 2019 - experts.umn.edu
Painful peripheral neuropathy is a dose-limiting side effect of cisplatin treatment. Using a
murine model of cisplatin-induced hyperalgesia, we determined whether a PPARγ synthetic …

Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress.

IA Khasabova, SG Khasabov, JK Olson, ML Uhelski… - Pain, 2019 - europepmc.org
Painful peripheral neuropathy is a dose-limiting side effect of cisplatin treatment. Using a
murine model of cisplatin-induced hyperalgesia, we determined whether a PPARγ synthetic …